Author(s): Sangeetha. R, Deepa Rajendiran, Soniya. R, Savithri. S


DOI: 10.52711/0974-360X.2024.00221   

Address: Sangeetha. R1*, Deepa Rajendiran2, Soniya. R3, Savithri. S4
1Lecturer, Department of Microbiology, SRM Dental College and Hospital, Ramapuram, Chennai, Tamil Nadu.
2Associate Professor, Department of Biochemistry, Madha Dental College and Hospital, Kundrathur, Chennai, Tamil Nadu.
3Lecturer, Department of Microbiology, SRM Dental College and Hospital, Ramapuram, Chennai, Tamil Nadu.
4Professor and Head, Department of Microbiology, SRM Dental College and Hospital, Ramapuram, Chennai, Tamil Nadu.
*Corresponding Author

Published In:   Volume - 17,      Issue - 3,     Year - 2024

Oral cancer is a global concern, with India contributing to one-third of total cases. The primary causes of the oral cancer include tobacco, alcohol, unhygienic practices, periodontal diseases, and viral infections. Treatment options include surgery, radiotherapy, and chemotherapy, which are expensive and limited in affordability. Conventional therapies can harbor toxicities, weakening the immune system. The emphasis on the development of novel therapeutic strategies for combatting oral cancer is the need of the hour. This review provides an overviewof both the conventional therapies which are a part of thetreatment regimen in oral cancer along with the novel therapies on the upfront such as the CRISPR/CAS technology, photodynamic therapy, Nanotheranostics etc.

Cite this article:
Sangeetha. R, Deepa Rajendiran, Soniya. R, Savithri. S. Therapeutic Strategies in Oral Cancer - A Review. Research Journal of Pharmacy and Technology. 2024; 17(3):1398-2. doi: 10.52711/0974-360X.2024.00221

Sangeetha. R, Deepa Rajendiran, Soniya. R, Savithri. S. Therapeutic Strategies in Oral Cancer - A Review. Research Journal of Pharmacy and Technology. 2024; 17(3):1398-2. doi: 10.52711/0974-360X.2024.00221   Available on:

1.    Dhanuthai K, Rojanawatsirivej S, Thosaporn W, Kintarak S, Subarnbhesaj A, Darling M, Kryshtalskyj E, Chiang CP, Shin HI, Choi SY, Lee SS, Aminishakib P. Oral cancer: A multicenter study. Med Oral Patol Oral Cir Bucal. 2018; 23(1): e23-e29. doi: 10.4317/medoral.21999. PMID: 29274153; PMCID: PMC5822535.
2.    Huang SH, O'Sullivan B. Oral cancer: Current role of radiotherapy and chemotherapy. Med Oral Patol Oral Cir Bucal. 2013; 18(2): e233-40. doi: 10.4317/medoral.18772.
3.    Rivera C. Essentials of oral cancer. Int J Clin Exp Pathol. 2015; 8(9): 11884-94.
4.    Nandini DB, Rao RS, Hosmani J, Khan S, Patil S, Awan KH. Novel therapies in the management of oral cancer: An update. Dis Mon. 2020; 66(12): 101036.doi: 10.1016/j.disamonth.2020.101036.
5.    Irani S. New Insights into Oral Cancer-Risk Factors and Prevention: A Review of Literature. Int J Prev Med. 2020; 11: 202. doi: 10.4103/ijpvm.IJPVM_403_18.
6.    Sharma S, Satyanarayana L, Asthana S, Shivalingesh KK, Goutham BS, Ramachandra S. Oral cancer statistics in India on the basis of first report of 29 population-based cancer registries. J Oral Maxillofac Pathol. 2018 Jan-Apr;22(1):18-26. doi: 10.4103/jomfp.JOMFP_113_17.
7.    S.K. Singh, Ayantika Biswas, Parul Puri. An epidemiology of self-reported cancer in India: A Decomposition analysis based on women in late-reproductive age-group, Clinical Epidemiology and Global Health. 2021; 9: 332-337
8.    Ram H, Sarkar J, Kumar H, Konwar R, Bhatt ML, Mohammad S. Oral cancer: risk factors and molecular pathogenesis. J Maxillofac Oral Surg. 2011; 10(2): 132-7. doi: 10.1007/s12663-011-0195-z.
9.    Karunakaran K, Muniyan R. Genetic alterations and clinical dimensions of oral cancer: a review. Mol Biol Rep. 2020; 47(11): 9135-9148. doi: 10.1007/s11033-020-05927-0.
10.    Shariff AI, Syed S, Shelby RA, Force J, Clarke JM, D'Alessio D, Corsino L. Novel cancer therapies and their association with diabetes. J Mol Endocrinol. 2019; 62(2): R187-R199. doi: 10.1530/JME-18-0002.
11.    Rajendran R. Oral leukoplakia (leukokeratosis): Compilation of facts and figures. J Oral MaxillofacPathol. 2004; 8: 58-68.
12.    Jatti Patil D, Nagaraju R. Personalised Precision Medicine - A Novel Approach for Oral Cancer Management [Internet]. Oral Cancer - Current Concepts and Future Perspectives. IntechOpen; 2022.
13.    Omura K. Current status of oral cancer treatment strategies: surgical treatments for oral squamous cell carcinoma. Int J Clin Oncol. 2014; 19(3): 423-30. doi: 10.1007/s10147-014-0689-z. Epub 2014 Apr 1.
14.    Hartner L. Chemotherapy for Oral Cancer. Dent Clin North Am. 2018; 62(1): 87-97. doi: 10.1016/j.cden.2017.08.006. Epub 2017 Oct 12.
15.    Arya L, Brizuela M. Oral Management of Patients Undergoing Radiation Therapy. [Updated 2023 Mar 19]. In: StatPearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2023 Jan-. Available from:
16.    Kirthi Koushik, A. S., and Charith Alva, R. (2022). Radiotherapy in Oral Cancers: Current Perspective and Future Directions. IntechOpen. doi: 10.5772/intechopen.99557.
17.    Viswanathan, A. N., Erickson, B. A., Ibbott, G. S., Small, W., Jr, & Eifel, P. J. The American College of Radiology and the American Brachytherapy Society practice parameter for the performance of low-dose-rate brachytherapy. Brachytherapy. 2017; 16(1): 68–74.
18.    Ganesh G. Dhakad, Gayatri D. Patil, Ashwini C. Nikum, Sangita P. Shirsat. Review on Radiation Therapy on Cancer. Research Journal of Pharmacology and Pharmacodynamics. 2022; 14(1): 4-2.
19.    Mijnheer B, Beddar S, Izewska J, Reft C. In vivo dosimetry in external beam radiotherapy. Med Phys. 2013; 40(7): 070903. doi: 10.1118/1.4811216.
20.    Baliarsing AS, Kumar VV, Malik NA, Dilip KB. Reconstruction of maxillectomy defects using deep circumflex iliac artery-based composite free flap. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010; 109:e8–13.
21.    Iyer, S., &Thankappan, K. Maxillary reconstruction: Current concepts and controversies. Indian journal of plastic surgery:official publication of the Association of Plastic Surgeons of India. 20114; 47(1): 8–19.
22.    Yee S. Transoral Robotic Surgery. AORN Journal, 2017; 105(1): 73–84.
23.    Andaloro C, Widrich J. Total Laryngectomy. [Updated 2023 May 28]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from:
24.    Ahn MY, Yoon JH. Histone deacetylase 8 as a novel therapeutic target in oral squamous cell carcinoma. Oncol Rep. 2017; 37(1): 540-546. doi: 10.3892/or.2016.5280.
25.    Modak, B., Solomon, M. C., Karmakar, S., and Polley, S. Gene therapy as a treatment of oral cancer: An insight. Journal of Oral and Maxillofacial Pathology. JOMFP.  2013; 27(2): 390–395.
26.    Zhao Z, Li D, Wu Z, Wang Q, Ma Z, Zhang C. Research Progress and Prospect of Nanoplatforms for Treatment of Oral Cancer. Front Pharmacol. 2020; 11: 616101. doi: 10.3389/fphar.2020.616101.
27.    Kumazawa Y, Kawamura K, Sato T, Sato N, Konishi Y, Shimizu Y, Fukuda J, Kodama H, Tanaka T. HCG up-regulates survivin mRNA in human granulosa cells. Mol Hum Reprod. 2005; 11(3): 161-6. doi: 10.1093/molehr/gah146. Epub 2005 Feb 11. Erratum in: Mol Hum Reprod. 2005 May;11(5):469.
28.    Yang Y, Xu J, Ge S, Lai L. CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research. Front Med (Lausanne). 2021; 8: 649896. doi: 10.3389/fmed.2021.649896.
29.    Luk BT, Zhang L. Current advances in polymer-based nanotheranostics for cancer treatment and diagnosis. ACS Appl Mater Interfaces. 2014; 6(24): 21859-73. doi: 10.1021/am5036225.

Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

56th percentile
Powered by  Scopus

SCImago Journal & Country Rank

Recent Articles


Not Available